Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 317

The DOI matches its Crossref record; 573 of the 573 references it cites were found in a registry or an index.

Redox regulation: mechanisms, biology and therapeutic targets in diseases

Open access
Li, Bowen, Ming, Hui, Qin, Siyuan, Nice, Edouard C., Dong, Jingsi, Du, Zhongyan, Huang, Canhua·2025·Signal Transduction and Targeted Therapy

Abstract

Redox signaling acts as a critical mediator in the dynamic interactions between organisms and their external environment, profoundly influencing both the onset and progression of various diseases. Under physiological conditions, oxidative free radicals generated by the mitochondrial oxidative respiratory chain, endoplasmic reticulum, and NADPH oxidases can be effectively neutralized by NRF2-mediated antioxidant responses. These responses elevate the synthesis of superoxide dismutase (SOD), catalase, as well as key molecules like nicotinamide adenine dinucleotide phosphate (NADPH) and glutathione (GSH), thereby maintaining cellular redox homeostasis. Disruption of this finely tuned equilibrium is closely linked to the pathogenesis of a wide range of diseases. Recent advances have broadened our understanding of the molecular mechanisms underpinning this dysregulation, highlighting the pivotal roles of genomic instability, epigenetic modifications, protein degradation, and metabolic reprogramming. These findings provide a foundation for exploring redox regulation as a mechanistic basis for improving therapeutic strategies. While antioxidant-based therapies have shown early promise in conditions where oxidative stress plays a primary pathological role, their efficacy in diseases characterized by complex, multifactorial etiologies remains controversial. A deeper, context-specific understanding of redox signaling, particularly the roles of redox-sensitive proteins, is critical for designing targeted therapies aimed at re-establishing redox balance. Emerging small molecule inhibitors that target specific cysteine residues in redox-sensitive proteins have demonstrated promising preclinical outcomes, setting the stage for forthcoming clinical trials. In this review, we summarize our current understanding of the intricate relationship between oxidative stress and disease pathogenesis and also discuss how these insights can be leveraged to optimize therapeutic strategies in clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-024-02095-6

Cites

573 of 573 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 573 references

Research works printed but not linked: 34

  1. Zhang, C. et al. Modulatory effect of fructooligosaccharide against triphenyltin-induced oxidative stress and immune suppression in goldfish (Carassius auratus). Ecotoxicol. Environ. Saf. 212, 111966 (2021). · doi:10.1016/j.ecoenv.2021.111966
  2. Tischer, A., Moon-Tasson, L. & Auton, M. Removal of the vicinal disulfide enhances the platelet-capturing function of von Willebrand factor. Blood 141, 1469–1473 (2023). · doi:10.1182/blood.2022018803
  3. Zhou, J. et al. A novel role for endoplasmic reticulum protein 46 (ERp46) in platelet function and arterial thrombosis in mice. Blood 139, 2050–2065 (2022). · doi:10.1182/blood.2021012055
  4. Zhou, H. et al. Cysteine thiol-based post-translational modification: what do we know about transcription factors? Trends Plant Sci. 28, 415–428 (2023). · doi:10.1016/j.tplants.2022.11.007
  5. Lu, X. et al. Natural antioxidant-based nanodrug for atherosclerosis treatment. Small 19, e2303459 (2023). · doi:10.1002/smll.202303459
  6. Tai, W. et al. Rapamycin attenuates the paraquat-induced pulmonary fibrosis through activating Nrf2 pathway. J. Cell Physiol. 235, 1759–1768 (2020). · doi:10.1002/jcp.29094
  7. Cimprich, K. A. et al. The crosstalk between DNA repair and immune responses. Mol. Cell 83, 3582–3587 (2023). · doi:10.1016/j.molcel.2023.09.022
  8. Moorefield, B. Adding complexity to NHEJ. Nat. Struct. Mol. Biol. 28, 703 (2021). · doi:10.1038/s41594-021-00664-9
  9. Yue, R. et al. GSH/APE1 cascade-activated nanoplatform for imaging therapy resistance dynamics and enzyme-mediated adaptive ferroptosis. ACS Nano 17, 13792–13810 (2023). · doi:10.1021/acsnano.3c03443
  10. Zhao, K. et al. Enhancement of Xrcc1-mediated base excision repair improves the genetic stability and pluripotency of iPSCs. Sci. Bull. 67, 1126–1130 (2022). · doi:10.1016/j.scib.2022.04.003
  11. London, R. E. XRCC1 - Strategies for coordinating and assembling a versatile DNA damage response. DNA Repair 93, 102917 (2020). · doi:10.1016/j.dnarep.2020.102917
  12. Farag, N. et al. Folding-upon-repair DNA nanoswitches for monitoring the activity of DNA repair enzymes. Angew. Chem. Int. Ed. Engl. 60, 7283–7289 (2021). · doi:10.1002/anie.202016223
  13. Wu, S. et al. PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma. Neuro Oncol. 23, 920–931 (2021). · doi:10.1093/neuonc/noab003
  14. Basak, D. & Srivenugopal, K. S. Redox-mediated inactivation of MGMT DNA repair through thiolation or nitrosylation of the active site cysteine145 sensitizes human gliomas to alkylating agents in vitro and in xenograft models. Cancer Res. 77, 1121–1121 (2017). · doi:10.1158/1538-7445.am2017-1121
  15. Shimamura, A. Telomere biology disorders: ends and (genetic) means. Blood 139, 1776–1777 (2022). · doi:10.1182/blood.2021014855
  16. Agudelo Garcia, P. A. & Berger, S. L. Genetics meets epigenetics in treg cells and autoimmunity. Immunity 52, 897–899 (2020). · doi:10.1016/j.immuni.2020.05.009
  17. Krause, D. S. The Fox(o) and the HDAC. Blood 135, 1416–1417 (2020). · doi:10.1182/blood.2020005291
  18. Jaffe, I. Z. Histone acetyltransferases in smooth muscle cell phenotype switching: redundant no longer. Circulation 145, 1738–1740 (2022). · doi:10.1161/circulationaha.122.060363
  19. Wrighton, K. H. p300/CBP keeps chromatin silent. Nat. Struct. Mol. Biol. 29, 1039 (2022). · doi:10.1038/s41594-022-00873-w
  20. Chakraborty, R. et al. Histone acetyltransferases p300 and CBP coordinate distinct chromatin remodeling programs in vascular smooth muscle plasticity. Circulation 145, 1720–1737 (2022). · doi:10.1161/circulationaha.121.057599
  21. Troussicot, L. et al. Disulfide-bond-induced structural frustration and dynamic disorder in a peroxiredoxin from MAS NMR. J. Am. Chem. Soc. 145, 10700–10711 (2023). · doi:10.1021/jacs.3c01200
  22. Narayan, M. Revisiting the formation of a native disulfide bond: consequences for protein regeneration and beyond. Molecules 25, 5337 (2020). · doi:10.3390/molecules25225337
  23. Oka, S., Watanabe, T., Chin, A. & Sadoshima, J. Oxidative stress inhibits mTOR through intermolecular disulfide bond formation with deptor in cardiomyocytes. Circulation 138, A14119–A14119 (2018).
  24. Zhang, H. et al. Melatonin improves the quality of maternally aged oocytes by maintaining intercellular communication and antioxidant metabolite supply. Redox Biol. 49, 102215 (2022). · doi:10.1016/j.redox.2021.102215
  25. Schweiger, P. J. et al. Extracellular matrix interactions provide tumor cells with an escape mechanism for commitment to differentiation. Gastroenterology 163, 1688–1690.e1683 (2022). · doi:10.1053/j.gastro.2022.08.036
  26. Mast cell migration and organization in tissues depend on integrin-ECM interactions. Nat. Immunol. 24, 899–900 (2023). · doi:10.1038/s41590-023-01494-1
  27. Rosenberg, N. et al. Integrin-mediated cell adhesion requires extracellular disulfide exchange regulated by protein disulfide isomerase. Exp. Cell Res. 381, 77–85 (2019). · doi:10.1016/j.yexcr.2019.04.017
  28. Chiang, C. et al. Therapeutic potential of targeting MKK3-p38 axis with capsaicin for nasopharyngeal carcinoma. Theranostics 10, 7906–7920 (2020). · doi:10.7150/thno.45191
  29. Gong, F. X. et al. De-dimerization of PTB is catalyzed by PDI and is involved in the regulation of p53 translation. Nucleic Acids Res. 49, 9342–9352 (2021). · doi:10.1093/nar/gkab708
  30. Crunkhorn, S. Reversing inflammaging. Nat. Rev. Drug Discov. 19, 168 (2020).
  31. Chen, Y. R. & Jarosz, D. F. Both ROSy and grim: the landscape of protein redox during aging. Cell Metab. 31, 662–663 (2020). · doi:10.1016/j.cmet.2020.03.016
  32. Guan, Q. & Du, C. Antioxidant nanozymes for prevention of diseased kidney from failure. Kidney Int. 102, 961–963 (2022). · doi:10.1016/j.kint.2022.08.003
  33. Camuglia, A. C. et al. Impact of N-acetylcysteine on endothelial function, B-type natriuretic peptide and renal function in patients with the cardiorenal syndrome: a pilot cross over randomised controlled trial. Heart Lung Circ. 22, 256–259 (2013). · doi:10.1016/j.hlc.2012.10.012
  34. Giannone, C. et al. Biogenesis of secretory immunoglobulin M requires intermediate non-native disulfide bonds and engagement of the protein disulfide isomerase ERp44. EMBO J. 41, e108518 (2022). · doi:10.15252/embj.2021108518

Metadata

Authors
Li, B., Ming, H., Qin, S., Nice, E. C., Dong, J., Du, Z., & Huang, C.
Venue
Signal Transduction and Targeted Therapy
Published
2025-03-07
Volume
10
Issue
1
Pages
72-72
ISSN
2059-3635 (ISSN-L)
OpenAlex
W4408177304
Cited by
317
References
573
FWCI
81.03
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Redox regulation: mechanisms, biology and therapeutic targets in diseases. https://app.cochat.ai/papers/10.1038/s41392-024-02095-6
The paper
Li, B., Ming, H., Qin, S., Nice, E. C., Dong, J., Du, Z., & Huang, C. (2025). Redox regulation: mechanisms, biology and therapeutic targets in diseases. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-024-02095-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.